Publications by authors named "Isabella Sassi"

Claim this Profile
R
Real-world use of multigene signatures in early breast cancer: differences to clinical trials.
Luca Licata, Rita De Sanctis, Andrea Vingiani, Deborah Cosentini, Monica Iorfida, Isabella Sassi

Breast Cancer Res Treat· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role and evaluation of pathologic response in early breast cancer specimens after neoadjuvant therapy: consensus statement.
Elena Guerini-Rocco, Gerardo Botti, Maria Pia Foschini, Caterina Marchiò, Mauro Giuseppe Mastropasqua, Isabella Sassi

Tumori· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PET/MRI for Staging the Axilla in Breast Cancer: Current Evidence and the Rationale for SNB vs. PET/MRI Trials.
Rosa Di Micco, Letizia Santurro, Maria Luisa Gasparri, Veronica Zuber, Giovanni Cisternino, Isabella Sassi

Cancers (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Risk-Benefit Ratio Adaptation of Breast Cancer Care at the Epicenter of COVID-19 Outbreak.
Giulia Viale, Luca Licata, Lorenzo Sica, Stefania Zambelli, Patrizia Zucchinelli, Isabella Sassi

Oncologist· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype" [Eur. J. Surg. Oncol. 45, (6) (2019) 969-975].
Rosa Di Micco, Veronica Zuber, Enrico Fiacco, Federica Carriero, M Ilaria Gattuso, Isabella Sassi

Eur J Surg Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
Rosa Di Micco, Veronica Zuber, Enrico Fiacco, Federica Carriero, M Ilaria Gattuso, Isabella Sassi

Eur J Surg Oncol· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short formalin fixation and rapid microwave processing do not affect HER2 testing.
Isabella Sassi, Francesca Invernizzi, Claudio Doglioni

Recent Results Cancer Res· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MR-guided stereotactic breast biopsy using a mixed ferromagnetic-nonmagnetic coaxial system with 12- to 18-gauge needles: clinical experience and long-term outcome.
Elena Belloni, Pietro Panizza, Silvia Ravelli, Francesco De Cobelli, Simone Gusmini, Isabella Sassi

Radiol Med· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CDC25A protein stability represents a previously unrecognized target of HER2 signaling in human breast cancer: implication for a potential clinical relevance in trastuzumab treatment.
Emanuela Brunetto, Anna Maria Ferrara, Francesca Rampoldi, Anna Talarico, Elena Dal Cin, Isabella Sassi

Neoplasia· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexplained neonatal respiratory distress due to congenital surfactant deficiency.
Marco Somaschini, Lawrence M Nogee, Isabella Sassi, Olivier Danhaive, Silvia Presi

J Pediatr· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Genetic basis in chronic interstitial familial pneumopathy. Familial study of SFTPC].
Marco Somaschini, Alessandra Cavazza, Silvia Riva, Isabella Sassi, Paola Carrera

Pediatr Med Chir· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nonmyeloablative conditioning followed by hematopoietic cell allografting and donor lymphocyte infusions for patients with metastatic renal and breast cancer.
Marco Bregni, Anna Dodero, Jacopo Peccatori, Alessandra Pescarollo, Massimo Bernardi, Isabella Sassi

Blood· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis